| 1 | Non‐coding RNAs to treat vascular smooth muscle cell dysfunction | 4.8 | 14 | Citations (PDF) |
| 2 | Functional screening identifies miRNAs with a novel function inhibiting vascular smooth muscle cell proliferation | 6.1 | 5 | Citations (PDF) |
| 3 | Targeted approach for next-generation coronary stents | 2.6 | 2 | Citations (PDF) |
| 4 | Loss of conserved long non-coding RNA MIR503HG leads to altered NOTCH pathway signalling and left ventricular non-compaction cardiomyopathy | 5.7 | 8 | Citations (PDF) |
| 5 | Transcriptional signatures of endothelial cells shape immune responses in cardiopulmonary health and disease | 3.7 | 6 | Citations (PDF) |
| 6 | Clonal Expansion in Cardiovascular Pathology | 2.4 | 15 | Citations (PDF) |
| 7 | Extracellular vesicles from differentiated stem cells contain novel proangiogenic miRNAs and induce angiogenic responses at low doses | 6.1 | 19 | Citations (PDF) |
| 8 | Epigenetic control of vascular endothelial function revealed by multi-omics | 2.6 | 4 | Citations (PDF) |
| 9 | Endothelial to mesenchymal transition: at the axis of cardiovascular health and disease | 5.7 | 102 | Citations (PDF) |
| 10 | The dual effects of miR-222 in cardiac hypertrophy: bridging pathological and physiological paradigms | 5.7 | 4 | Citations (PDF) |
| 11 | P2X7 receptor knockout does not alter renal function or prevent angiotensin II-induced kidney injury in F344 rats | 2.7 | 7 | Citations (PDF) |
| 12 | Development of a long noncoding RNA-based machine learning model to predict COVID-19 in-hospital mortality | 11.0 | 20 | Citations (PDF) |
| 13 | Endothelial Heterogeneity in the Response to Autophagy Drives Small Vessel Muscularization in Pulmonary Hypertension | 13.1 | 38 | Citations (PDF) |
| 14 | Deciphering endothelial heterogeneity in health and disease at single-cell resolution: progress and perspectives | 5.7 | 76 | Citations (PDF) |
| 15 | Human and murine fibroblast single-cell transcriptomics reveals fibroblast clusters are differentially affected by ageing and serum cholesterol | 5.7 | 46 | Citations (PDF) |
| 16 | The endothelial-enriched lncRNA LINC00607 mediates angiogenic function | 5.4 | 28 | Citations (PDF) |
| 17 | The role of the endothelium in severe acute respiratory syndrome coronavirus 2 infection and pathogenesis | 1.1 | 6 | Citations (PDF) |
| 18 | INKILN
is a Novel Long Noncoding RNA Promoting Vascular Smooth Muscle Inflammation via Scaffolding MKL1 and USP10 | 13.1 | 65 | Citations (PDF) |
| 19 | Transcriptional regulators of arterial and venous identity in the developing mammalian embryo | 1.1 | 14 | Citations (PDF) |
| 20 | Dissecting the transcriptome in cardiovascular disease | 5.7 | 40 | Citations (PDF) |
| 21 | Deficiency of myeloid PHD proteins aggravates atherogenesis via macrophage apoptosis and paracrine fibrotic signalling | 5.7 | 34 | Citations (PDF) |
| 22 | Hooked on heart regeneration: the zebrafish guide to recovery | 5.7 | 59 | Citations (PDF) |
| 23 | Single-cell RNA sequencing profiling of mouse endothelial cells in response to pulmonary arterial hypertension | 5.7 | 129 | Citations (PDF) |
| 24 | MRI and CT coronary angiography in survivors of COVID-19 | 2.6 | 29 | Citations (PDF) |
| 25 | Mapping the developing human cardiac endothelium at single-cell resolution identifies MECOM as a regulator of arteriovenous gene expression | 5.7 | 70 | Citations (PDF) |
| 26 | Coronary Artery and Cardiac Disease in Patients With Type 2 Myocardial Infarction: A Prospective Cohort Study | 13.1 | 74 | Citations (PDF) |
| 27 | Cutting a path to effective delivery of genome engineering machinery | 5.7 | 1 | Citations (PDF) |
| 28 | Protective role of chaperone-mediated autophagy against atherosclerosis | 5.3 | 96 | Citations (PDF) |
| 29 | History of Wrist Arthroscopy | 0.4 | 13 | Citations (PDF) |
| 30 | (Epi)transcriptomics in cardiovascular and neurological complications of COVID-19 | 0.9 | 11 | Citations (PDF) |
| 31 | Manganese-Enhanced Magnetic Resonance Imaging in Takotsubo Syndrome | 13.1 | 17 | Citations (PDF) |
| 32 | Tissue-selective endothelial arousal revealed by vascular endothelial growth factor gene transfer | 5.7 | 0 | Citations (PDF) |
| 33 | Antagonism of miRNA in heart failure: first evidence in human | 2.6 | 15 | Citations (PDF) |
| 34 | The Influence of the LINC00961/SPAAR Locus Loss on Murine Development, Myocardial Dynamics, and Cardiac Response to Myocardial Infarction | 3.2 | 18 | Citations (PDF) |
| 35 | Novel Transcript Discovery Expands the Repertoire of Pathologically-Associated, Long Non-Coding RNAs in Vascular Smooth Muscle Cells | 3.2 | 9 | Citations (PDF) |
| 36 | Lost in Translation: Progress and Challenges in Advanced Therapies to Treat CVDs | 6.1 | 2 | Citations (PDF) |
| 37 | Lack of Evidence of Angiotensin-Converting Enzyme 2 Expression and Replicative Infection by SARS-CoV-2 in Human Endothelial Cells | 13.1 | 203 | Citations (PDF) |
| 38 | Jumping on base editing to repair the diseased cardiovascular system in vivo | 5.7 | 0 | Citations (PDF) |
| 39 | MIR503HG Loss Promotes Endothelial-to-Mesenchymal Transition in Vascular Disease | 8.6 | 79 | Citations (PDF) |
| 40 | CARMN
Loss Regulates Smooth Muscle Cells and Accelerates Atherosclerosis in Mice | 8.6 | 87 | Citations (PDF) |
| 41 | In Vitro and In Vivo Evaluation of Human Adenovirus Type 49 as a Vector for Therapeutic Applications | 2.2 | 9 | Citations (PDF) |
| 42 | Fli1
+
cells transcriptional analysis reveals an Lmo2–Prdm16 axis in angiogenesis | 5.3 | 22 | Citations (PDF) |
| 43 | Histone deacetylase 9 promotes endothelial-mesenchymal transition and an unfavorable atherosclerotic plaque phenotype | 6.8 | 110 | Citations (PDF) |
| 44 | Human AdV-20-42-42, a Promising Novel Adenoviral Vector for Gene Therapy and Vaccine Product Development | 2.4 | 15 | Citations (PDF) |
| 45 | Nuclear S-nitrosylation impacts tissue regeneration in zebrafish | 11.0 | 24 | Citations (PDF) |
| 46 | Transcriptional dynamics of pluripotent stem cell-derived endothelial cell differentiation revealed by single-cell RNA sequencing | 2.6 | 56 | Citations (PDF) |
| 47 | Osteocalcin Regulates Arterial Calcification Via Altered Wnt Signaling and Glucose Metabolism | 3.3 | 89 | Citations (PDF) |
| 48 | Novel Plaque Enriched Long Noncoding RNA in Atherosclerotic Macrophage Regulation (PELATON) | 4.3 | 61 | Citations (PDF) |
| 49 | Extracellular Vesicle miRNAs in the Promotion of Cardiac Neovascularisation | 2.2 | 39 | Citations (PDF) |
| 50 | Progression and regression of left ventricular hypertrophy and myocardial fibrosis in a mouse model of hypertension and concomitant cardiomyopathy | 0.5 | 35 | Citations (PDF) |
| 51 | T-Cell–Derived miRNA-214 Mediates Perivascular Fibrosis in Hypertension | 8.6 | 107 | Citations (PDF) |
| 52 | Manganese-enhanced T1 mapping to quantify myocardial viability: validation with 18F-fluorodeoxyglucose positron emission tomography | 2.7 | 12 | Citations (PDF) |
| 53 | The LINC00961 transcript and its encoded micropeptide, small regulatory polypeptide of amino acid response, regulate endothelial cell function | 5.7 | 59 | Citations (PDF) |
| 54 | miR-96 and miR-183 differentially regulate neonatal and adult postinfarct neovascularization | 3.7 | 16 | Citations (PDF) |
| 55 | Human Adenovirus Serotype 5 Is Sensitive to IgM-Independent Neutralization In Vitro and In Vivo | 2.2 | 9 | Citations (PDF) |
| 56 | The Human-Specific and Smooth Muscle Cell-Enriched LncRNA SMILR Promotes Proliferation by Regulating Mitotic CENPF mRNA and Drives Cell-Cycle Progression Which Can Be Targeted to Limit Vascular Remodeling | 8.6 | 152 | Citations (PDF) |
| 57 | Manganese-enhanced MRI of the myocardiumHeart, 2019, 105, 1695-1700 | 2.6 | 29 | Citations (PDF) |
| 58 | Extracellular vesicle cross-talk between pulmonary artery smooth muscle cells and endothelium during excessive TGF-β signalling: implications for PAH vascular remodelling | 6.2 | 55 | Citations (PDF) |
| 59 | Importance of Long Non-coding RNAs in the Development and Disease of Skeletal Muscle and Cardiovascular Lineages | 2.8 | 57 | Citations (PDF) |
| 60 | Endothelial function and dysfunction in the cardiovascular system: the long non-coding road | 5.7 | 60 | Citations (PDF) |
| 61 | Single-cell transcriptome analyses reveal novel targets modulating cardiac neovascularization by resident endothelial cells following myocardial infarction | 2.6 | 207 | Citations (PDF) |
| 62 | Skin immunisation activates an innate lymphoid cell-monocyte axis regulating CD8+ effector recruitment to mucosal tissues | 11.0 | 13 | Citations (PDF) |
| 63 | The function of long non-coding RNAs in vascular biology and disease | 1.2 | 30 | Citations (PDF) |
| 64 | TGFβ, smooth muscle cells and coronary artery disease: a review | 2.8 | 120 | Citations (PDF) |
| 65 | The function of miR-143, miR-145 and the MiR-143 host gene in cardiovascular development and disease | 1.2 | 107 | Citations (PDF) |
| 66 | Endothelial to Mesenchymal Transition in Cardiovascular Disease | 0.7 | 630 | Citations (PDF) |
| 67 | αvβ3 Integrin Is Required for Efficient Infection of Epithelial Cells with Human Adenovirus Type 26 | 2.4 | 37 | Citations (PDF) |
| 68 | Robust Revascularization in Models of Limb Ischemia Using a Clinically Translatable Human Stem Cell-Derived Endothelial Cell Product | 6.1 | 63 | Citations (PDF) |
| 69 | Targeting Non-coding RNA in Vascular Biology and Disease | 2.2 | 53 | Citations (PDF) |
| 70 | Unravelling atherosclerotic heterogeneity by single cell RNA sequencing | 2.7 | 1 | Citations (PDF) |
| 71 | What matters in Cardiovascular Research? Scientific discovery driving clinical delivery | 5.7 | 10 | Citations (PDF) |
| 72 | A new “lnc” between non-coding RNA and cardiac regeneration | 5.7 | 5 | Citations (PDF) |
| 73 | Non-coding RNAs in vascular disease – from basic science to clinical applications: scientific update from the Working Group of Myocardial Function of the European Society of Cardiology | 5.7 | 40 | Citations (PDF) |
| 74 | Tissue Inhibitor of Metalloproteinase–3 (TIMP-3) induces FAS dependent apoptosis in human vascular smooth muscle cells | 1.5 | 16 | Citations (PDF) |
| 75 | Generation and characterization of a novel candidate gene therapy and vaccination vector based on human species D adenovirus type 56 | 1.9 | 21 | Citations (PDF) |
| 76 | Defining a Novel Role for the Coxsackievirus and Adenovirus Receptor in Human Adenovirus Serotype 5 Transduction
In Vitro
in the Presence of Mouse Serum | 2.4 | 15 | Citations (PDF) |
| 77 | Cardiovascular Gene Therapy: Past, Present, and Future | 6.1 | 173 | Citations (PDF) |
| 78 | PET Cell Tracking Using 18F-FLT is Not Limited by Local Reuptake of Free Radiotracer | 2.7 | 13 | Citations (PDF) |
| 79 | The Function and Therapeutic Potential of Long Non-coding RNAs in Cardiovascular Development and Disease | 3.9 | 105 | Citations (PDF) |
| 80 | Atherosclerosis development | 2.7 | 0 | Citations (PDF) |
| 81 | Role of noncoding RNA in vascular remodelling | 2.7 | 33 | Citations (PDF) |
| 82 | Targeting non-coding RNA for the therapy of renal disease | 2.9 | 28 | Citations (PDF) |
| 83 | Smooth Muscle Enriched Long Noncoding RNA (
SMILR
) Regulates Cell Proliferation | 13.1 | 219 | Citations (PDF) |
| 84 | lncRNA/MicroRNA interactions in the vasculature | 2.7 | 229 | Citations (PDF) |
| 85 | Regulation and Function of miR‐214 in Pulmonary Arterial Hypertension | 1.3 | 35 | Citations (PDF) |
| 86 | miR‐34a−/− mice are susceptible to diet‐induced obesity | 2.9 | 62 | Citations (PDF) |
| 87 | The relevance of coagulation factor X protection of adenoviruses in human sera | 3.2 | 20 | Citations (PDF) |
| 88 | A Role for the Long Noncoding RNA SENCR in Commitment and Function of Endothelial Cells | 6.1 | 149 | Citations (PDF) |
| 89 | Development of Novel Adenoviral Vectors to Overcome Challenges Observed With HAdV-5–based Constructs | 6.1 | 99 | Citations (PDF) |
| 90 | Retargeting FX-binding-ablated HAdV-5 to vascular cells by inclusion of the RGD-4C peptide in hexon hypervariable region 7 and the HI loop | 1.9 | 12 | Citations (PDF) |
| 91 | Reducing In-Stent Restenosis | 0.7 | 106 | Citations (PDF) |
| 92 | Micro(RNA) management of smooth muscle cell phenotype and response to vascular injury: Figure 1 | 5.7 | 1 | Citations (PDF) |
| 93 | Manipulating Adenovirus Hexon Hypervariable Loops Dictates Immune Neutralisation and Coagulation Factor X-dependent Cell Interaction In Vitro and In Vivo | 2.9 | 50 | Citations (PDF) |
| 94 | A Sex-Specific MicroRNA-96/5-Hydroxytryptamine 1B Axis Influences Development of Pulmonary Hypertension | 5.0 | 68 | Citations (PDF) |
| 95 | Efficient Transduction of Primary Vascular Cells by the Rare Adenovirus Serotype 49 Vector | 2.3 | 30 | Citations (PDF) |
| 96 | MicroRNA-143 Activation Regulates Smooth Muscle and Endothelial Cell Crosstalk in Pulmonary Arterial Hypertension | 8.6 | 296 | Citations (PDF) |
| 97 | Impaired vascular function and repair in patients with premature coronary artery disease | 1.5 | 14 | Citations (PDF) |
| 98 | Endothelial Apoptosis in Pulmonary Hypertension Is Controlled by a microRNA/Programmed Cell Death 4/Caspase-3 Axis | 4.7 | 95 | Citations (PDF) |
| 99 | P238Efficient gene transfer to human vascular cells in vitro and ex vivo using adenovirus serotype 49 | 5.7 | 0 | Citations (PDF) |
| 100 | Retargeting Adenovirus Serotype 48 Fiber Knob Domain by Peptide Incorporation | 2.3 | 14 | Citations (PDF) |
| 101 | MicroRNA-214 Antagonism Protects against Renal Fibrosis | 0.3 | 140 | Citations (PDF) |
| 102 | The importance of coagulation factors binding to adenovirus: historical perspectives and implications for gene delivery | 3.7 | 23 | Citations (PDF) |
| 103 | Profiling of transcriptional and epigenetic changes during directed endothelial differentiation of human embryonic stem cells identifies FOXA2 as a marker of early mesoderm commitment | 4.2 | 13 | Citations (PDF) |
| 104 | MicroRNAs in pulmonary arterial remodeling | 3.5 | 68 | Citations (PDF) |
| 105 | Gene therapy for cardiovascular disease: Perspectives and potential | 1.2 | 24 | Citations (PDF) |
| 106 | Identification of novel small molecule inhibitors of adenovirus gene transfer using a high throughput screening approach | 8.3 | 15 | Citations (PDF) |
| 107 | Assessment of a novel, capsid-modified adenovirus with an improved vascular gene transfer profile | 0.8 | 18 | Citations (PDF) |
| 108 | The atypical mechanosensitive microRNA-712 derived from pre-ribosomal RNA induces endothelial inflammation and atherosclerosis | 11.0 | 232 | Citations (PDF) |
| 109 | Canonical Transforming Growth Factor-β Signaling Regulates Disintegrin Metalloprotease Expression in Experimental Renal Fibrosis via miR-29 | 2.8 | 74 | Citations (PDF) |
| 110 | MicroRNA regulation of endothelial homeostasis and commitment—implications for vascular regeneration strategies using stem cell therapies | 2.6 | 16 | Citations (PDF) |
| 111 | miRNA-21 is dysregulated in response to vein grafting in multiple models and genetic ablation in mice attenuates neointima formation | 2.6 | 72 | Citations (PDF) |
| 112 | Transient but Not Genetic Loss of miR‐451 is Protective in the Development of Pulmonary Arterial Hypertension | 1.3 | 16 | Citations (PDF) |
| 113 | Pseudotyping the adenovirus serotype 5 capsid with both the fibre and penton of serotype 35 enhances vascular smooth muscle cell transduction | 3.2 | 31 | Citations (PDF) |
| 114 | An analysis of the function and expression of D6 on lymphatic endothelial cellsBlood, 2013, 121, 3768-3777 | 3.6 | 77 | Citations (PDF) |
| 115 | How do microRNAs affect vascular smooth muscle cell biology? | 2.7 | 30 | Citations (PDF) |
| 116 | Manipulation of Adenovirus Interactions with Host Factors for Gene Therapy Applications | 2.5 | 47 | Citations (PDF) |
| 117 | Gene Therapy by Targeted Adenovirus-mediated Knockdown of Pulmonary Endothelial Tph1 Attenuates Hypoxia-induced Pulmonary Hypertension | 6.1 | 58 | Citations (PDF) |
| 118 | Combined Fiber Modifications Both to Target α
v
β
6
and Detarget the Coxsackievirus–Adenovirus Receptor Improve Virus Toxicity Profiles
In Vivo
but Fail to Improve Antitumoral Efficacy Relative to Adenovirus Serotype 5 | 2.3 | 41 | Citations (PDF) |
| 119 | MicroRNA and vascular remodelling in acute vascular injury and pulmonary vascular remodelling | 5.7 | 103 | Citations (PDF) |
| 120 | A Role for miR-145 in Pulmonary Arterial Hypertension | 8.6 | 282 | Citations (PDF) |
| 121 | Integrase-Deficient Lentiviral Vectors Mediate Efficient Gene Transfer to Human Vascular Smooth Muscle Cells with Minimal Genotoxic Risk | 2.3 | 18 | Citations (PDF) |
| 122 | Ad5:Ad48 Hexon Hypervariable Region Substitutions Lead to Toxicity and Increased Inflammatory Responses Following Intravenous Delivery | 6.1 | 66 | Citations (PDF) |
| 123 | Prevention of coronary in-stent restenosis and vein graft failure: Does vascular gene therapy have a role? 2012, 136, 23-34 | | 29 | Citations (PDF) |
| 124 | Derivation of Vascular Endothelial Cells from Human Embryonic Stem Cells Under GMP-Compliant Conditions: Towards Clinical Studies in Ischaemic Disease | 1.3 | 21 | Citations (PDF) |
| 125 | Role of MicroRNAs 99b, 181a, and 181b in the Differentiation of Human Embryonic Stem Cells to Vascular Endothelial Cells | 2.7 | 95 | Citations (PDF) |
| 126 | Biodistribution and inflammatory profiles of novel penton and hexon double-mutant serotype 5 adenoviruses | 8.3 | 41 | Citations (PDF) |
| 127 | Vein graft failure: current clinical practice and potential for gene therapeutics | 3.2 | 48 | Citations (PDF) |
| 128 | The Role of miRNA in Stem Cell Pluripotency and Commitment to the Vascular Endothelial Lineage | 1.3 | 8 | Citations (PDF) |
| 129 | Deregulation of microRNA-503 Contributes to Diabetes Mellitus–Induced Impairment of Endothelial Function and Reparative Angiogenesis After Limb Ischemia | 13.1 | 396 | Citations (PDF) |
| 130 | miR-21 and miR-214 Are Consistently Modulated during Renal Injury in Rodent Models | 2.8 | 107 | Citations (PDF) |
| 131 | Pluripotent stem cell differentiation into vascular cells: A novel technology with promises for vascular re(generation) 2011, 129, 29-49 | | 97 | Citations (PDF) |
| 132 | MicroRNAs regulating cell pluripotency and vascular differentiation | 1.2 | 14 | Citations (PDF) |
| 133 | Sustained Reduction of Vein Graft Neointima Formation by Ex Vivo TIMP-3 Gene Therapy | 13.1 | 73 | Citations (PDF) |
| 134 | Inhibition of In-Stent Stenosis by Oral Administration of Bindarit in Porcine Coronary Arteries | 4.3 | 32 | Citations (PDF) |
| 135 | Serotonin transporter, sex, and hypoxia: microarray analysis in the pulmonary arteries of mice identifies genes with relevance to human PAH | 1.4 | 58 | Citations (PDF) |
| 136 | Coagulation factor X mediates adenovirus type 5 liver gene transfer in non-human primates (Microcebus murinus) | 3.2 | 44 | Citations (PDF) |
| 137 | In utero administration of Ad5 and AAV pseudotypes to the fetal brain leads to efficient, widespread and long-term gene expression | 3.2 | 42 | Citations (PDF) |
| 138 | Vascular-Targeting Antioxidant Therapy in a Model of Hypertension and Stroke | 1.4 | 17 | Citations (PDF) |
| 139 | Biodistribution and retargeting of FX-binding ablated adenovirus serotype 5 vectorsBlood, 2010, 116, 2656-2664 | 3.6 | 103 | Citations (PDF) |
| 140 | Functional characterization of a 13-bp deletion (c.-1522_-1510del13) in the promoter of the von Willebrand factor gene in type 1 von Willebrand diseaseBlood, 2010, 116, 3645-3652 | 3.6 | 38 | Citations (PDF) |
| 141 | Erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA) blocks differentiation and maintains the expression of pluripotency markers in human embryonic stem cells | 2.3 | 6 | Citations (PDF) |
| 142 | Transcription Factor Egr-1 Is Essential for Maximal Matrix Metalloproteinase-9 Transcription by Tumor Necrosis Factor α | 2.6 | 82 | Citations (PDF) |
| 143 | Tropism-Modification Strategies for Targeted Gene Delivery Using Adenoviral Vectors | 2.2 | 117 | Citations (PDF) |
| 144 | Requirements for Receptor Engagement during Infection by Adenovirus Complexed with Blood Coagulation Factor X | 2.9 | 75 | Citations (PDF) |
| 145 | Genome-Wide Association Study of Blood Pressure Extremes Identifies Variant near UMOD Associated with Hypertension | 2.2 | 338 | Citations (PDF) |
| 146 | Dynamic Changes in Lung MicroRNA Profiles During the Development of Pulmonary Hypertension due to Chronic Hypoxia and Monocrotaline | 4.3 | 325 | Citations (PDF) |
| 147 | Derivation of Endothelial Cells From Human Embryonic Stem Cells by Directed Differentiation | 4.3 | 151 | Citations (PDF) |
| 148 | Lentivirus-mediated Reprogramming of Somatic Cells in the Absence of Transgenic Transcription Factors | 6.1 | 38 | Citations (PDF) |
| 149 | Dysregulation of cadherins in the intercalated disc of the spontaneously hypertensive stroke-prone rat | 2.7 | 9 | Citations (PDF) |
| 150 | Therapeutic angiogenesis in diabetic apolipoprotein E-deficient mice using bone marrow cells, functional hemangioblasts and metabolic intervention | 1.9 | 18 | Citations (PDF) |
| 151 | Effect of Neutralizing Sera on Factor X-Mediated Adenovirus Serotype 5 Gene Transfer | 2.4 | 79 | Citations (PDF) |
| 152 | Serotype Chimeric and Fiber-Mutated Adenovirus Ad5/19p-HIT for Targeting Renal Cancer and Untargeting the Liver | 2.3 | 18 | Citations (PDF) |
| 153 | Transduction of Liver Metastases After Intravenous Injection of Ad5/35 or Ad35 Vectors With and Without Factor X-Binding Protein Pretreatment | 2.3 | 23 | Citations (PDF) |
| 154 | Influence of Coagulation Factor X on In Vitro and In Vivo Gene Delivery by Adenovirus (Ad) 5, Ad35, and Chimeric Ad5/Ad35 Vectors | 6.1 | 42 | Citations (PDF) |
| 155 | Onset of Experimental Severe Cardiac Fibrosis Is Mediated by Overexpression of Angiotensin-Converting Enzyme 2 | 4.7 | 39 | Citations (PDF) |
| 156 | Use of in vivo phage display to engineer novel adenoviruses for targeted delivery to the cardiac vasculature | 1.8 | 24 | Citations (PDF) |
| 157 | Mouse adenovirus type 1 and human adenovirus type 5 differ in endothelial cell tropism and liver targeting | 1.6 | 13 | Citations (PDF) |
| 158 | Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transferBlood, 2009, 114, 965-971 | 3.6 | 181 | Citations (PDF) |
| 159 | Performance of AAV8 vectors expressing human factor IX from a hepatic-selective promoter following intravenous injection into rats | 0.9 | 24 | Citations (PDF) |
| 160 | Viral and non-viral gene delivery and its role in pluripotent stem cell engineering | 3.4 | 12 | Citations (PDF) |
| 161 | Adenovirus Serotype 5 Hexon Mediates Liver Gene Transfer | 23.8 | 617 | Citations (PDF) |
| 162 | British Society for Gene Therapy Annual Conference 2008 | 2.3 | 0 | Citations (PDF) |
| 163 | Luciferin Detection After Intranasal Vector Delivery Is Improved by Intranasal Rather Than Intraperitoneal Luciferin Administration | 2.3 | 36 | Citations (PDF) |
| 164 | In Vitro and In Vivo Properties of Adenovirus Vectors with Increased Affinity to CD46 | 2.4 | 67 | Citations (PDF) |
| 165 | Arteriolar Genesis and Angiogenesis Induced by Endothelial Nitric Oxide Synthase Overexpression Results in a Mature Vasculature | 4.3 | 43 | Citations (PDF) |
| 166 | In Vivo Modulation of Nogo-B Attenuates Neointima Formation | 6.1 | 38 | Citations (PDF) |
| 167 | Development of Renal-targeted Vectors Through Combined In Vivo Phage Display and Capsid Engineering of Adenoviral Fibers From Serotype 19p | 6.1 | 45 | Citations (PDF) |
| 168 | Adenovirus 5 Fibers Mutated at the Putative HSPG-binding Site Show Restricted Retargeting with Targeting Peptides in the HI Loop | 6.1 | 56 | Citations (PDF) |
| 169 | Multiphoton Microscopy for 3-Dimensional Imaging of Lymphocyte Recruitment Into Apolipoprotein-E–Deficient Mouse Carotid Artery | 13.1 | 34 | Citations (PDF) |
| 170 | Targeting of Adenovirus Serotype 5 (Ad5) and 5/47 Pseudotyped Vectors In Vivo: Fundamental Involvement of Coagulation Factors and Redundancy of CAR Binding by Ad5 | 2.4 | 73 | Citations (PDF) |
| 171 | Influence of Coagulation Factor Zymogens on the Infectivity of Adenoviruses Pseudotyped with Fibers from Subgroup D | 2.4 | 62 | Citations (PDF) |
| 172 | Brain protection using autologous bone marrow cell, metalloproteinase inhibitors, and metabolic treatment in cerebral ischemia | 5.3 | 81 | Citations (PDF) |
| 173 | Modifications of the radiosensitivity of a renal cancer cell line as a consequence of stable TIMP-1 overexpression | 1.3 | 7 | Citations (PDF) |
| 174 | Membrane-type 1-Matrix Metalloproteinase Regulates Intracellular Adhesion Molecule-1 (ICAM-1)-mediated Monocyte Transmigration | 1.3 | 78 | Citations (PDF) |
| 175 | Metalloproteinase Inhibition Has Differential Effects on Alloimmunity, Autoimmunity, and Histopathology in the Transplanted Lung | 1.7 | 12 | Citations (PDF) |
| 176 | Novel vectors forin vivogene delivery to vascular tissue | 1.9 | 9 | Citations (PDF) |
| 177 | The Influence of Blood on In Vivo Adenovirus Bio-distribution and Transduction | 6.1 | 65 | Citations (PDF) |
| 178 | The use of tissue inhibitors of matrix metalloproteinases to increase the efficacy of a tumor necrosis factor/interferonγ antitumor therapy | 3.7 | 10 | Citations (PDF) |
| 179 | Neuroprotective effect of adenoviral-mediated gene transfer of TIMP-1 and -2 in ischemic brain injury | 3.2 | 47 | Citations (PDF) |
| 180 | APOE ε3 Gene Transfer Attenuates Brain Damage after Experimental Stroke | 3.1 | 15 | Citations (PDF) |
| 181 | Collagenase-3 (MMP-13) Enhances Remodeling of Three-Dimensional Collagen and Promotes Survival of Human Skin Fibroblasts | 1.8 | 62 | Citations (PDF) |
| 182 | Engineering adeno-associated virus 2 vectors for targeted gene delivery to atherosclerotic lesions | 3.2 | 37 | Citations (PDF) |
| 183 | In vitro susceptibility to the pro-apoptotic effects of TIMP-3 gene delivery translates to greater in vivo efficacy versus gene delivery for TIMPs-1 or -2 | 1.9 | 41 | Citations (PDF) |
| 184 | Multiple vitamin K-dependent coagulation zymogens promote adenovirus-mediated gene delivery to hepatocytesBlood, 2006, 108, 2554-2561 | 3.6 | 274 | Citations (PDF) |
| 185 | Opportunities for gene therapy in preventing vein graft failure after coronary artery bypass surgery | 3.2 | 13 | Citations (PDF) |
| 186 | Tissue inhibitor of metalloproteinases-2 improves antitumor efficacy of a replicating adenovirus in vivo | 3.2 | 10 | Citations (PDF) |
| 187 | Cardiac transgenic matrix metalloproteinase-2 expression directly induces impaired contractility | 5.7 | 80 | Citations (PDF) |
| 188 | Lesional Overexpression of Matrix Metalloproteinase-9 Promotes Intraplaque Hemorrhage in Advanced Lesions But Not at Earlier Stages of Atherogenesis | 4.3 | 201 | Citations (PDF) |
| 189 | Suppression of Atherosclerotic Plaque Progression and Instability by Tissue Inhibitor of Metalloproteinase-2 | 13.1 | 152 | Citations (PDF) |
| 190 | Heparan Sulfate Proteoglycan Binding Properties of Adeno-Associated Virus Retargeting Mutants and Consequences for Their In Vivo Tropism | 2.4 | 131 | Citations (PDF) |
| 191 | 117. HSPG Binding Properties of Adeno- Associated Virus Retargeting Mutants and Consequences for Their In Vivo Tropism | 6.1 | 0 | Citations (PDF) |
| 192 | Vascular bed-targeted in vivo gene delivery using tropism-modified adeno-associated viruses | 6.1 | 126 | Citations (PDF) |
| 193 | Inhibition of Urokinase-Type Plasminogen Activator or Matrix Metalloproteinases Prevents Cardiac Injury and Dysfunction During Viral Myocarditis | 13.1 | 106 | Citations (PDF) |
| 194 | Cell-selective viral gene delivery vectors for the vasculature | 1.8 | 34 | Citations (PDF) |
| 195 | Heterogeneous effects of tissue inhibitors of matrix metalloproteinases on cardiac fibroblasts | 2.2 | 119 | Citations (PDF) |
| 196 | Ultrasound-mediated delivery of TIMP-3 plasmid DNA into saphenous vein leads to increased lumen size in a porcine interposition graft model | 3.2 | 58 | Citations (PDF) |
| 197 | Adeno-associated virus (AAV)-7 and -8 poorly transduce vascular endothelial cells and are sensitive to proteasomal degradation | 3.2 | 58 | Citations (PDF) |
| 198 | Targeting endothelial cells with adenovirus expressing nitric oxide synthase prevents elevation of blood pressure in stroke-prone spontaneously hypertensive rats | 6.1 | 60 | Citations (PDF) |
| 199 | The influence of adenovirus fiber structure and function on vector development for gene therapy | 6.1 | 173 | Citations (PDF) |
| 200 | Enhanced gene transfer activity of peptide-targeted gene-delivery vectors | 2.7 | 39 | Citations (PDF) |
| 201 | Loss or Inhibition of uPA or MMP-9 Attenuates LV Remodeling and Dysfunction after Acute Pressure Overload in Mice | 2.8 | 157 | Citations (PDF) |
| 202 | Efficient isolation of peptide ligands for the endothelial cell protein C receptor (EPCR) using candidate receptor phage display biopanning | 2.0 | 7 | Citations (PDF) |
| 203 | Targeted Gene Delivery to Vascular Tissue In Vivo by Tropism-Modified Adeno-Associated Virus Vectors | 13.1 | 194 | Citations (PDF) |
| 204 | Overexpression of p53 Increases Lumen Size and Blocks Neointima Formation in Porcine Interposition Vein Grafts | 6.1 | 48 | Citations (PDF) |
| 205 | Development of Efficient Viral Vectors Selective for Vascular Smooth Muscle Cells | 6.1 | 104 | Citations (PDF) |
| 206 | Effect of adenovirus serotype 5 fiber and penton modifications on in vivo tropism in rats | 6.1 | 105 | Citations (PDF) |
| 207 | Dual targeting of gene delivery by genetic modification of adenovirus serotype 5 fibers and cell-selective transcriptional control | 3.2 | 25 | Citations (PDF) |
| 208 | Designing gene delivery vectors for cardiovascular gene therapy | 2.9 | 46 | Citations (PDF) |
| 209 | Title is missing! | 0.9 | 11 | Citations (PDF) |
| 210 | In vitro andin vivo characterisation of endothelial cell selective adenoviral vectors | 1.6 | 48 | Citations (PDF) |
| 211 | Adenovirus-mediated overexpression of tissue inhibitor of metalloproteinases-1 in the liver: efficient protection against T-cell lymphoma and colon carcinoma metastasis | 1.6 | 25 | Citations (PDF) |
| 212 | Adenoviral Serotype 5 Vectors Pseudotyped with Fibers from Subgroup D Show Modified TropismIn VitroandIn Vivo | 2.3 | 53 | Citations (PDF) |
| 213 | Differential alterations in the expression and activity of matrix metalloproteinases 2 and 9 after transient cerebral ischemia in mice | 3.6 | 46 | Citations (PDF) |
| 214 | Targeting gene therapy vectors to the vascular endothelium | 3.4 | 5 | Citations (PDF) |
| 215 | Stroma Formation and Angiogenesis by Overexpression of Growth Factors, Cytokines, and Proteolytic Enzymes in Human Skin Grafted to SCID Mice | 1.8 | 43 | Citations (PDF) |
| 216 | Enhancement of lipopolysaccharide-stimulated JNK activity in rat aortic smooth muscle cells by pharmacological and adenovirus-mediated inhibition of inhibitory kappa B kinase signalling | 4.8 | 12 | Citations (PDF) |
| 217 | Tissue inhibitor of metalloproteinases-3 induces apoptosis in melanoma cells by stabilization of death receptors | 5.2 | 168 | Citations (PDF) |
| 218 | A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2 | 22.8 | 649 | Citations (PDF) |
| 219 | Inhibition of Matrix Metalloproteinases by Lung TIMP-1 Gene Transfer Limits Monocrotaline-Induced Pulmonary Vascular Remodeling in Rats | 2.3 | 53 | Citations (PDF) |
| 220 | Transductional and transcriptional targeting of cancer cells using genetically engineered viral vectors | 6.7 | 32 | Citations (PDF) |
| 221 | Third-generation lentivirus vectors efficiently transduce and phenotypically modify vascular cells: implications for gene therapy | 2.7 | 70 | Citations (PDF) |
| 222 | Tissue inhibitor of metalloproteinase 1 inhibits excitotoxic cell death in neurons | 2.2 | 85 | Citations (PDF) |
| 223 | Oxidation-sensitive mechanisms, vascular apoptosis and atherosclerosis | 8.4 | 97 | Citations (PDF) |
| 224 | Targeting AAV vectors | 6.1 | 6 | Citations (PDF) |
| 225 | Gene Therapy for Cardiovascular Disease | 5.9 | 20 | Citations (PDF) |
| 226 | Tissue Inhibitor of Metalloproteinase-3 Induces a Fas-associated Death Domain-dependent Type II Apoptotic Pathway | 1.3 | 127 | Citations (PDF) |
| 227 | Inhibition of retinal neovascularisation by gene transfer of soluble VEGF receptor sFlt-1 | 3.2 | 156 | Citations (PDF) |
| 228 | Antitumor Activity and Bystander Effect of Adenovirally Delivered Tissue Inhibitor of Metalloproteinases-3 | 6.1 | 77 | Citations (PDF) |
| 229 | Adenovirus-mediated overexpression of extracellular superoxide dismutase improves endothelial dysfunction in a rat model of hypertension | 3.2 | 95 | Citations (PDF) |
| 230 | Sorsby's fundus dystrophy mutant tissue inhibitors of metalloproteinase-3 induce apoptosis of retinal pigment epithelial and MCF-7 cells | 1.8 | 23 | Citations (PDF) |
| 231 | Peptide-Retargeted Adenovirus Encoding a Tissue Inhibitor of Metalloproteinase-1 Decreases Restenosis after Intravascular Gene Transfer | 6.1 | 48 | Citations (PDF) |
| 232 | Expression of collagenase‐3 (MMP‐13) enhances invasion of human fibrosarcoma HT‐1080 cells | 2.8 | 48 | Citations (PDF) |
| 233 | Development and Use of Gene Transfer for Treatment of Cardiovascular Disease | 0.2 | 16 | Citations (PDF) |
| 234 | Neutrophil Proteinases in Hydrochloric Acid- and Endotoxin-Induced Acute Lung Injury: Evaluation of Interstitial Protease Activity by in situ Zymography | 1.9 | 26 | Citations (PDF) |
| 235 | Gene Transfer to the Vasculature | 1.7 | 5 | Citations (PDF) |
| 236 | Paradoxical effects of tissue inhibitor of metalloproteinases 1 gene transfer in collagen-induced arthritis | 6.4 | 49 | Citations (PDF) |
| 237 | Combined transductional and transcriptional targeting improves the specificity of transgene expression in vivo | 20.2 | 223 | Citations (PDF) |
| 238 | Wild-type p53 gene transfer inhibits neointima formation in human saphenous vein by modulation of smooth muscle cell migration and induction of apoptosis | 3.2 | 82 | Citations (PDF) |
| 239 | Efficient and Selective AAV2-Mediated Gene Transfer Directed to Human Vascular Endothelial Cells | 6.1 | 217 | Citations (PDF) |
| 240 | Inhibition of transcription factor NF-κB reduces matrix metalloproteinase-1, -3 and -9 production by vascular smooth muscle cells | 5.7 | 360 | Citations (PDF) |
| 241 | Ablating Adenovirus Type 5 Fiber–CAR Binding and HI Loop Insertion of the SIGYPLP Peptide Generate an Endothelial Cell-Selective Adenovirus | 6.1 | 139 | Citations (PDF) |
| 242 | Localization of the Death Domain of Tissue Inhibitor of Metalloproteinase-3 to the N Terminus | 1.3 | 113 | Citations (PDF) |
| 243 | Catalytic Nucleic Acids: From Lab to Applications | 10.5 | 39 | Citations (PDF) |
| 244 | Rat Amnion Type IV Collagen Composition and Metabolism: Implications for Membrane Breakdown1 | 1.8 | 57 | Citations (PDF) |
| 245 | Expression of Tissue Inhibitor of Metalloproteinase-1, -2, and -3 During Neointima Formation in Organ Cultures of Human Saphenous Vein | 4.3 | 51 | Citations (PDF) |
| 246 | Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure | 22.8 | 765 | Citations (PDF) |
| 247 | Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by overexpression of TIMP-3 | 4.2 | 274 | Citations (PDF) |
| 248 | Nuclear Factor κB Activity Is Essential for Matrix Metalloproteinase-1 and -3 Upregulation in Rabbit Dermal Fibroblasts | 1.5 | 175 | Citations (PDF) |
| 249 | Targets for gene therapy of vein grafts | 1.0 | 16 | Citations (PDF) |
| 250 | Gene transfer of tissue inhibitor of metalloproteinase-2 inhibits metalloproteinase activity and neointima formation in human saphenous veins | 3.2 | 144 | Citations (PDF) |
| 251 | Biological consequences of a point mutation at codon 969 of the FMS gene | 0.7 | 12 | Citations (PDF) |
| 252 | Synergistic upregulation of metalloproteinase‐9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF‐κB | 1.8 | 486 | Citations (PDF) |
| 253 | Adenovirus-Mediated Gene Transfer of the Human TIMP-1 Gene Inhibits Smooth Muscle Cell Migration and Neointimal Formation in Human Saphenous Vein | 2.3 | 203 | Citations (PDF) |
| 254 | Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis. | 6.8 | 427 | Citations (PDF) |
| 255 | Prevention of vein graft failure: potential applications for gene therapy | 5.7 | 27 | Citations (PDF) |
| 256 | Allelic loss of the FMS gene in acute myeloid leukaemia | 0.7 | 7 | Citations (PDF) |
| 257 | Development of recombinant adenoviruses that drive high level expression of the human metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 and -2 genes: Characterization of their infection into rabbit smooth muscle cells and human MCF-7 adenocarcinoma cells | 3.5 | 52 | Citations (PDF) |
| 258 | Divergent regulation by growth factors and cytokines of 95 kDa and 72 kDa gelatinases and tissue inhibitors or metalloproteinases-1, -2, and -3 in rabbit aortic smooth muscle cells | 2.3 | 284 | Citations (PDF) |
| 259 | Upregulation of Basement Membrane–Degrading Metalloproteinase Secretion After Balloon Injury of Pig Carotid Arteries | 8.6 | 101 | Citations (PDF) |
| 260 | A novel CSF-1 binding factor in a patient in complete remission following cytotoxic therapy for lymphoma | 1.6 | 2 | Citations (PDF) |
| 261 | FMS mutations in patients following cytotoxic therapy for lymphoma | 0.7 | 16 | Citations (PDF) |
| 262 | Title is missing! 0 | | 1 | Citations (PDF) |
| 263 | The British Society for Gene and Cell Therapy at 20 (2003–2023) | 2.3 | 0 | Citations (PDF) |
| 264 | ERC-funded Advanced Grant: creating molecular polypills | 2.6 | 0 | Citations (PDF) |
| 265 | Missing ‘lncs’: how insufficient scrutiny can lead to misrepresentation of long non-coding RNAs (lncRNAs) and their function in cardiovascular disease | 2.6 | 1 | Citations (PDF) |
| 266 | Effective Transcriptional Induction of the CARMN/miR-143/145 Complex Locus in Smooth Muscle Cells Using CRISPR Activation | 4.3 | 2 | Citations (PDF) |
| 267 | Gene therapy in cardiac and vascular diseases: a review of approaches to treat genetic and common cardiovascular diseases with novel gene-based therapeutics | 5.7 | 18 | Citations (PDF) |
| 268 | Endothelial to mesenchymal transition in cardiovascular diseases: molecular insights and clinical perspectives | 2.6 | 17 | Citations (PDF) |
| 269 | Ribonucleic acid and gene therapies in cardiovascular disease: clinical applications, delivery challenges and emerging precision tools | 2.6 | 1 | Citations (PDF) |
| 270 | The Medical Research Council/British Heart Foundation Centre of Research Excellence in Advanced Cardiac Therapies (REACT) | 2.6 | 0 | Citations (PDF) |
| 271 | DAPK2 Regulates PKM2 Phosphorylation at Threonine 45 to Facilitate Disturbed Flow-Induced Atherosclerosis | 13.1 | 0 | Citations (PDF) |
| 272 | Vascular remodeling outcomes in human arteriovenous fistula maturation are associated to long non-coding RNA expression | 5.7 | 0 | Citations (PDF) |
| 273 | A causal ‘lnc’ between exercise and ageing in the cardiac vasculature | 2.6 | 0 | Citations (PDF) |
| 274 | Is the future of cardiac repair cell-free? | 2.6 | 0 | Citations (PDF) |
| 275 | The dark genome in cardiovascular medicine | 2.6 | 1 | Citations (PDF) |
| 276 | In search of LncDACH1 – a perceived intronic long non-coding RNA lacking fundamental genomic annotation evidence | 11.0 | 0 | Citations (PDF) |
